CLINICAL_TRIALS
trial_result
· 2022-06-16
Clinical Trial Update: Study of BMS-986158 in Subjects With Select Advanced Cancers [Phase 1, Phase 2]
Summary
Phase 1/2 study of BMS-986158 in subjects with advanced cancers has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Advanced Tumors | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-06-16